These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9009654)

  • 21. [Oral isolates of Saccharomyces in patients with oral fungal infection and their susceptibility to antifungal drugs].
    Chen FC; Lin M
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2007 Feb; 25(1):37-41. PubMed ID: 17375574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nystatin pastilles and suspension in the treatment of oral candidosis.
    Millns B; Martin MV
    Br Dent J; 1996 Sep; 181(6):209-11. PubMed ID: 8885454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
    Grasela TH; Goodwin SD; Pasko MT; Walawander CA; Raebel MA
    Ann Pharmacother; 1994 Feb; 28(2):252-60. PubMed ID: 8173147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
    Austin N; Darlow BA; McGuire W
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003478. PubMed ID: 19821309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of invasive Candida infections in preterm infants: the time is now.
    Kaufman DA
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):393-9. PubMed ID: 18662105
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-Nübling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral and gastrointestinal candidosis: prophylaxis during immunosuppressive therapy.
    Prentice AG
    Mycoses; 1989; 32 Suppl 2():42-6. PubMed ID: 2700221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance.
    Llabot JM; Manzo RH; Allemandi DA
    J Pharm Sci; 2009 May; 98(5):1871-6. PubMed ID: 18803261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
    Isaacs D
    Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal prophylaxis in immunocompromised hosts.
    Reents S; Goodwin SD; Singh V
    Ann Pharmacother; 1993 Jan; 27(1):53-60. PubMed ID: 8431623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nystatin prophylaxis and treatment in severely immunodepressed patients.
    Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2002; (4):CD002033. PubMed ID: 12519566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis.
    Boon JM; Lafeber HN; Mannetje AH; van Olphen AH; Smeets HL; Toorman J; van der Vlist GJ
    Mycoses; 1989 Jun; 32(6):312-5. PubMed ID: 2779612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
    Martins HP; da Silva MC; Paiva LC; Svidzinski TI; Consolaro ME
    Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nystatin prophylaxis in immunocompromised children.
    Taylor TL
    Ann Pharmacother; 1996 May; 30(5):534-5. PubMed ID: 8740337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimycotic Treatment of Oral Candidiasis in Warfarin Users.
    Iversen DB; Hellfritzsch M; Stage TB; Aabenhus RM; Lind BS; Pottegård A
    Am J Med; 2021 May; 134(5):e308-e312. PubMed ID: 33176127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 38. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral candidal infections and antimycotics.
    Ellepola AN; Samaranayake LP
    Crit Rev Oral Biol Med; 2000; 11(2):172-98. PubMed ID: 12002814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nystatin prophylaxis and treatment in severely immunodepressed patients.
    Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2002; (2):CD002033. PubMed ID: 12076436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.